Legal Representation
Attorney
Christopher N. Bolinger
Application History
28 events| Date | Code | Type | Description |
|---|---|---|---|
| May 7, 2007 | ABN1 | O | ABANDONMENT - EXPRESS MAILED |
| May 7, 2007 | MAB1 | O | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT |
| May 7, 2007 | ABN1 | O | ABANDONMENT - EXPRESS MAILED |
| May 7, 2007 | MAB1 | O | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT |
| May 2, 2007 | ALIE | A | ASSIGNED TO LIE |
| May 2, 2007 | LOAP | I | LETTER OF ABANDONMENT PROCESSED |
| May 2, 2007 | ALIE | A | ASSIGNED TO LIE |
| May 2, 2007 | LOAP | I | LETTER OF ABANDONMENT PROCESSED |
| Apr 3, 2007 | I | PAPER RECEIVED | |
| Apr 3, 2007 | I | PAPER RECEIVED | |
| Nov 30, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Nov 30, 2006 | CNRT | F | NON-FINAL ACTION MAILED |
| Nov 30, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Nov 30, 2006 | CNRT | F | NON-FINAL ACTION MAILED |
| Nov 27, 2006 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Nov 27, 2006 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Oct 20, 2006 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Oct 20, 2006 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Sep 27, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Sep 27, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Sep 22, 2006 | ALIE | A | ASSIGNED TO LIE |
| Sep 22, 2006 | ALIE | A | ASSIGNED TO LIE |
| Sep 15, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 15, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 14, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 14, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 7, 2006 | NWAP | I | NEW APPLICATION ENTERED IN TRAM |
| Apr 7, 2006 | NWAP | I | NEW APPLICATION ENTERED IN TRAM |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, premature ejaculation, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations namely, cholesterol preparations, insomnia preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations and ophthalmological preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005